Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 12, 2024BJU InternationalOpen Access

Evolution of European prostate cancer screening protocols and summary of ongoing trials

View Full Paper
Ask AI
Bookmark
Share

Authors

MHMeike J. van HartenErasmus MC Cancer InstituteMRMonique J. RoobolUniversité Claude Bernard Lyon 1PLPim J. van LeeuwenProstate Cancer Foundation of Australia

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Harten et al. (2024) studied this question.

synapsesocial.com/papers/6a109b6eb6f5ee040160dbbfhttps://doi.org/10.1111/bju.16311
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Lead Times and Overdetection Due to Prostate-Specific Antigen Screening: Estimates From the European Randomized Study of Screening for Prostate Cancer2003 · 1,075 citations
  2. 2Results from 22 years of Followup in the Göteborg Randomized Population-Based Prostate Cancer Screening Trial2022 · 97 citations
  3. 3Prostate MRI versus PSA screening for prostate cancer detection (the MVP Study): a randomised clinical trial2022 · 64 citations
  4. 4Personalized strategies in population screening for prostate cancer2020 · 25 citations
  5. 5Population‐based randomized trial of screening for clinically significant prostate cancer ProScreen: a pilot study2021 · 25 citations